Srinivas Rajsheker, MD
Clinical Cardiac Electrophysiology · Cincinnati, OHNPI 1114056959
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (52.1%), food and beverage and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Abbott at 39.6% of the total. 2025 is the largest year on record at $5,118, more than ten times the $413 reported in 2019. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in OH, where the typical reported total is $17,892.
Across 290 payments — averaging $65.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$7K
- Biotronik Inc.$3K
- Medtronic$2K
- Boston Scientific$2K
- Atricure, Inc.$2K
- Biosense Webster, Inc.$1K
- plus $2K from 11 others
Across 510 payments — averaging $155.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biotronik Inc.$79K
What the payments were for
- Travel & lodging$9,82752%
- Food & beverage$8,95047%
- Education$910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 114 | $7,468 |
| Biotronik Inc. | 42 | $2,883 |
| Medtronic(2 entities) | 47 | $2,210 |
| Boston Scientific | 11 | $1,903 |
| Atricure, Inc. | 11 | $1,726 |
| Biosense Webster, Inc. | 27 | $1,159 |
| Philips North America LLC | 3 | $393 |
| Cardiva Medical, Inc. | 19 | $384 |
| AOP Health US, LLC | 1 | $349 |
| Impulse Dynamics (USA) Inc. | 1 | $149 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $119 |
| AstraZeneca | 2 | $37 |
| Kestra Medical Technology Services, Inc. | 1 | $25 |
| Pfizer | 1 | $18 |
| Cook Medical LLC | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Elutia, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$4,366
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$1,557
- INGEVITY$1,454
- EVERA MRI XT DR SURESCAN$979
- AMPLATZER AMULET$932
- Acticor 7 VR-T DX$757
- Carto 3$756
- Rapiblyk$699
- AMVIA EDGE$509
- ATRICLIP LAA EXCLUSION SYSTEM$324
- OPTIMIZER$298
- (9520) IGT Devices Undivided$250
- CARDIOMEMS$185
- JOT DX$178
- ENSITE PRECISION$170
- AFFERA MAPPING SYSTEM$162
- EPD Solutions Und$143
- AMPLATZER TORQVUE 45 X 45$141
- AZURE XT DR MRI SURESCAN$139
- Acticor$130
How this compares
$18,868 in reported general payments places this provider in the 50th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
See all clinical cardiac electrophysiology providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 845 | $810,689 |
| XareltoRivaroxaban | 161 | $184,100 |
| EntrestoSacubitril/Valsartan | 38 | $27,275 |
| Metoprolol Succinate | 409 | $5,255 |
| CorlanorIvabradine Hcl | 11 | $3,984 |
| Flecainide Acetate | 65 | $3,463 |
| Amiodarone Hcl | 180 | $2,678 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 11 | $2,546 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 122 | $2,530 |
| Warfarin Sodium | 172 | $1,554 |
| SotalolSotalol Hcl | 46 | $768 |
| Pyridostigmine Bromide | 12 | $753 |
| Lisinopril | 73 | $657 |
| Carvedilol | 99 | $635 |
| Fludrocortisone Acetate | 15 | $572 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $18 | $810,689845 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
Other clinical cardiac electrophysiology in Cincinnati
- Alexandru CosteaCincinnati$188K
- Gaurang GandhiCincinnati$179K
- Dilesh PatelCincinnati$81K
- Marshall WinnerCincinnati$56K
- Emile DaoudCincinnati$46K
- Daniel PelchovitzCincinnati$43K
- Hemal ShahCincinnati$40K
- Wai TamCincinnati$40K
- Moses WananuCincinnati$38K
- Edward SchlossCincinnati$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.